Trials / Completed
CompletedNCT01173575
Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 209 (actual)
- Sponsor
- Infectopharm Arzneimittel GmbH · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This project aims to assess the clinical and microbiological efficacy of fosfomycin(FOM) in patients with bacterial infection. Primary objective: • To assess clinical and microbiological efficacy of FOM in patients with bacterial infection. Secondary objectives: * To determine the rate and severity of unexpected adverse events. * To determine the mean duration of therapy with FOM in patients with bacterial infection. Study design: Multi-center, non-interventional study
Detailed description
Please note that InfectoPharm Arzneimittel und Consilium GmbH has taken over sponsor responsibilities for all German sites of this clinical trial with Jannuary 2016 from J\&P MEDICAL RESEARCH LTD.
Conditions
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2010-08-02
- Last updated
- 2019-07-02
Locations
25 sites across 2 countries: Austria, Germany
Source: ClinicalTrials.gov record NCT01173575. Inclusion in this directory is not an endorsement.